Boston Scientific Corporation (BSX) — closed signal from September 26, 2025
Partial Published before the outcome was known, scored automatically when the window closed on December 25, 2025.
Predicted vs. what happened
What happened
Reached 36% of the predicted growth at its peak, without hitting the target.
The thesis — published September 26, 2025
The stock has fallen more than usual and could rebound soon, though some trend signals still point down. The company leads in single-use scopes used for digestive care, and that market is expected to grow about 28% a year. A U.S. trade review on medical imports could make prices swing. Consider buying in steps over the next 0-3 months as the recent average price flattens and buying strength improves.
Primary drivers
- Price looks washed out, hinting at a near-term rebound if selling pressure eases.
- Strong position in single-use scopes, a fast-growing area of hospital tools.
- U.S. import review may create bigger-than-normal day-to-day price swings.
- Add more only after the recent average price steadies and starts to tilt up.
How it played out
BSX: rebound faded before the target
Lyra published BSX on 2025-09-26 at 99.21, with 18% expected growth. The thesis pointed to a washed-out price that could rebound if selling eased, strength in single-use scopes for digestive care, possible U.S. import-review volatility, and a plan to add only after the recent average price steadied.
Inside the window, BSX rose to 105.65 on 2025-11-13, a 6.5% peak gain. It stayed below the 117.07 target and never reached it. By 2025-12-25, it ended at 96.13. The thesis partially played out, then faded.
What happened during the window
On 2025-10-22, Investor's Business Daily reported that Boston Scientific posted adjusted earnings of $0.75 per share on $5.07 billion in revenue for the third quarter. The same report said Watchman sales grew 35% and electrophysiology sales rose 63%.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.